Skip to main content

300K Solutions

300K Solutions at Advanced Therapies 2025: standardizing biomarker stabilization at room temperature

We had the pleasure of participating in the Advanced Therapies Meeting 2025.

At the event, 300K Solutions demonstrated how we are standardizing biomarker stabilization at room temperature, enhancing pre-analytical processes to improve the quality and reproducibility of results.

It was a great opportunity to exchange ideas with industry professionals, showcase our innovative solutions, and share how our technology can transform the management of biological samples in advanced therapy development.

Stay updated on our activities!

Tuvimos el placer de participar en el Advanced Therapies Meeting 2025.

Durante el evento, en 300K Solutions mostramos cómo estamos estandarizando la estabilización de biomarcadores a temperatura ambiente, optimizando los procesos pre-analíticos para mejorar la calidad y reproducibilidad de los resultados.

Fue una gran oportunidad para intercambiar ideas con profesionales del sector, mostrar nuestras soluciones innovadoras y compartir cómo nuestra tecnología puede transformar la gestión de muestras biológicas en el desarrollo de terapias avanzadas.

¡Mantente al día de nuestras actividades!​

One Technology. Infinite Possibilities.

DNA

RNA

PLASMA/ SERUM

BLOOD CELL FRACTION

WHOLE BLOOD

TISSUES

We are opening a collaborative space to explore and discuss potential applications of 300K technology.

Our goal is to foster knowledge exchange between researchers, clinicians and innovators interested in real-world use cases.

CONNECT, EXPLORE, AND EXCHANGE IDEAS ON 300K APPLICATIONS

Share:

More Posts

300K Solutions will be present at EHA2026

Blood-derived sample stabilization is a critical need in hematology and biomarker research. Current preservative-based solutions provide stability for only a few days, while longer storage often requires freezing—an approach that is not always feasible.
300K Solutions leverages freeze-drying technology to extend stability from days to months in blood cells and plasma/serum. This approach preserves sample integrity from collection to analysis, minimizing biomarker degradation and eliminating the need for refrigerated logistics.

Contact Us